University of Cambridge > Talks.cam > MRC LMB Seminar Series > Milstein Lecture 2022 - Project Lightspeed – The discovery of the first Covid-19 mRNA Vaccine

  Browse A-Z

Log in

Googledetails Microsoftdetails

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹ️ Information

Milstein Lecture 2022 - Project Lightspeed – The discovery of the first Covid-19 mRNA Vaccine

Download to your calendar using vCal

If you have a question about this talk, please contact Scientific Meetings Co-ordinator .

With the outbreak of the SARS Cov-2 pandemic in January 2020, we launched Project Lightspeed with the goal of developing a safe and effective mRNA vaccine in the shortest possible time without skipping the steps of regular vaccine development. The talk will cover the research and the findings that led to the discovery, development, and licensure of the first Covid-19 vaccine within 10 months after project initiation. The talk will provide immunological insights into the mechanisms of antibody and T cell immune responses triggered by the COVID -19 mRNA vaccine, into the mode of action of vaccine boosters, and report on research on Omicron-adapted vaccines. The lecture will conclude with our technological approach to establish mRNA production in other regions and democratize global access to innovative medicines.

This talk is part of the MRC LMB Seminar Series series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Photography Average on weekdays: 9166.9703504 kWh MR9, Pav. B

Other talks

Theophilus Richmond’s The First Crossing: The Transition from Slavery to Indentureship in the Caribbean and the Case of the Black Slave on the Hesperus Online Causal Inference Seminar Haematology and Palliative Care Talk TBC Paediatric Medicine and Rheumatology Quantum optics with organic molecules
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity